Health Care & Life Sciences » Biotechnology | Applied Genetic Technologies Corp.

Applied Genetic Technologies Corp. | Mutual Funds

Mutual Funds that own Applied Genetic Technologies Corp.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Vanguard Total Stock Market Index Fund
246,541
1.37%
0
0%
07/31/2018
CI Global Health Sciences Corporate Class
229,000
1.27%
10,000
0.54%
06/30/2017
Vanguard Extended Market Index Fund
207,936
1.14%
0
0%
07/31/2018
DFA US Small Cap Value Portfolio
197,761
1.1%
0
0%
04/30/2018
DFA US Targeted Value Portfolio
106,900
0.59%
21,656
0%
04/30/2018
94,273
0.52%
94,273
0.01%
12/31/2016
Bridgeway Ultra Small Company Market Fund
92,400
0.51%
0
0.09%
12/31/2017
GuideStone Small Cap Equity Fund
60,063
0.33%
0
0.04%
12/31/2017
DFA US Small Cap Portfolio
59,037
0.33%
38,708
0%
04/30/2018
49,900
0.28%
-8,000
0.06%
04/30/2018

About Applied Genetic Technologies

View Profile
Address
14193 NW
Alachua Florida 32615
United States
Employees -
Website http://www.agtc.com
Updated 07/08/2019
Applied Genetic Technologies Corp. is a clinical-stage biotechnology company, which engages in the development of gene therapy products designed to transform the lives of patients with severe diseases in ophthalmology. Its product candidates are designed to treat X-linked retinoschisis, Achromatopsia, and X-linked retinitis pigmentosa. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.